No Data
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company, today announced that it will release financial results for the second quarter of
While Institutions Own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), Private Equity Firms Are Its Largest Shareholders With 49% Ownership
CCORF Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Maintains Target Price $6
CCORF analyst Kyle Mikson CFA maintains $Akoya Biosciences(AKYA.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 24.8% and a t
Craig-Hallum Initiates Akoya Biosciences(AKYA.US) With Buy Rating, Announces Target Price $7.5
Craig-Hallum analyst William Bonello initiates coverage on $Akoya Biosciences(AKYA.US)$ with a buy rating, and sets the target price at $7.5.According to TipRanks data, the analyst has a success rate
Express News | Akoya Biosciences Shares Rise 7.1% Premarket After Craig-Hallum Initiates Coverage With Buy Rating
Express News | Akoya Biosciences, Inc. : Craig-Hallum Initiates Coverage With Buy Rating and Target Price $7.5